Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Salarius Pharmaceuticals, Inc. (FLKS) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/12/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/12/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
11/08/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
11/08/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/06/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/06/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/06/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/12/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/13/2019 4/A Jordan Scott (Chief Business Officer) has filed a Form 4 on Salarius Pharmaceuticals, Inc.
Txns: Granted 10,000 options to buy @ $8, valued at $80k
03/25/2016 4/A Westphal Christoph H (President and CEO) has filed a Form 4 on Flex Pharma, Inc.
Txns: Bought 23,951 shares @ $11.78, valued at $282.1k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy